Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Achilles Therapeutics

    NASDAQ: ACHL · Real-Time Price · USD
    1.48
    0.00 (0.00%)
    At close: Mar 20, 2025, 3:59 PM

    Achilles Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 4.73M 3.69M 3.29M
    Gross Profit
    		 -4.73M -3.69M -3.29M
    Operating Income
    		 -75.25M -78.38M -64.19M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 -69.17M -71.06M -61.06M
    Net Income
    		 -69.67M -71.18M -61.1M
    Selling & General & Admin
    		 12.34M 21.12M 21.97M
    Research & Development
    		 67.65M 57.26M 42.22M
    Other Expenses
    		 -9.4M 7.32M 3.13M
    Operating Expenses
    		 75.25M 78.38M 64.19M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 -4.67M n/a n/a
    Cost & Expenses
    		 75.25M 78.38M 64.19M
    Income Tax Expense
    		 491K 111K 37K
    Shares Outstanding (Basic)
    		 39.97M 39.14M 28.65M
    Shares Outstanding (Diluted)
    		 39.97M 39.14M 28.65M
    EPS (Basic)
    		 -1.74 -1.82 -2.13
    EPS (Diluted)
    		 -1.74 -1.82 -2.13
    EBITDA
    		 -70.44M -78.38M -57.77M
    EBIT
    		 -75.16M -71.02M -64.09M
    Depreciation & Amortization
    		 4.73M 3.69M 3.29M

    Add to Watchlist